多参数动态对比成像用于脑肿瘤体素级定量评估
本研究于2023年3月至2024年4月前瞻性评估多参数动态对比成像(mpDYCI)技术,该技术基于MR Multitasking动态T1和T2*映射,可同时定量脑组织灌注、微血管通透性、跨膜水外流和磁化率。在6名健康参与者和55名脑肿瘤参与者中,mpDYCI指标显示良好至优秀的重复性(ICC≥0.80)和与参考标准的一致性(误差6.86%-15.21%或ICC≥0.93),并能捕捉肿瘤内异质性,有助于鉴别脑转移瘤的治疗相关效应与真性进展。
要点
- mpDYCI单次7.5分钟扫描、单剂量对比剂注射即可同时定量灌注、通透性、水外流和磁化率。
- 各mpDYCI指标间体素级相关性低(除一对外相关系数≤0.33),提示信息互补。
- mpDYCI指标重复性ICC≥0.80,与参考标准误差6.86%-15.21%或ICC≥0.93。
核心结论
- mpDYCI通过单次7.5分钟扫描和单剂量对比剂注射,可同时定量灌注、通透性、水外流和磁化率,从而实现脑肿瘤的全面体素级表征。
研究设计与样本
- 前瞻性研究,2023年3月至2024年4月纳入6名健康参与者(平均年龄33岁,范围27-48岁,3名女性)和55名脑肿瘤参与者(平均年龄56岁,范围24-81岁,36名女性),评估mpDYCI技术的重复性和准确性。
关键影像表现/征象
- 直方图分析、体素聚类和组织学验证证实mpDYCI能够捕捉肿瘤内异质性。
- 除一对外,各对mpDYCI指标间体素级相关系数≤0.33,提示各指标提供互补信息。
- mpDYCI在鉴别脑转移瘤治疗相关效应与真性肿瘤进展方面展现出潜力。
诊断标准与关键数值
- mpDYCI指标重复性良好至优秀(ICC≥0.80)。
- 与参考标准一致性优秀(百分比误差范围6.86%-15.21%或ICC≥0.93)。
临床应用与阅片要点
- mpDYCI可整合到常规脑肿瘤成像协议中,实现体素级多方面定量评估。
- 单次7.5分钟扫描和单剂量对比剂注射即可获得灌注、通透性、水外流和磁化率多参数信息。
- 各指标间体素级相关性低,提示联合应用可提供互补信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To develop a multiparametric dynamic contrast imaging (mpDYCI) technique that enables simultaneous quantification of brain tissue perfusion, microvasculature permeability, transmembrane water efflux, and susceptibility and can be integrated into the routine brain tumor imaging protocol for voxelwise multifaceted quantitative brain tumor assessment. Materials and Methods In this prospective study conducted from March 2023 to April 2024, the mpDYCI technique was evaluated. The mpDYCI technique builds on an MR Multitasking-based dynamic T1 and T2* mapping method and incorporates several technical optimizations in pulse sequence, image reconstruction, T1/T2* quantification, and quantitative metric estimation to achieve robust whole-brain multiparametric quantification. The intersession repeatability and accuracy of mpDYCI metrics were assessed, using intraclass correlation coefficient (ICC), through digital phantom and in vivo experiments involving healthy individuals and individuals with brain tumors. The feasibility of integrating mpDYCI into the routine brain imaging protocol and its clinical utilities based on complementary information from intrinsically coregistered multiple quantitative metrics were also explored. Results In vivo experiments were performed in six healthy participants (mean age, 33 years; range, 27-48 years; three female) and 55 participants with brain tumors (mean age, 56 years; range, 24-81 years; 36 female). Quantitative metrics derived from mpDYCI demonstrated good to excellent repeatability (ICC ≥ 0.80) and excellent agreement with reference standards (range, 6.86%-15.21% percentage error or ICC ≥ 0.93). Histogram analysis, voxel clustering, and histologic validation confirmed the capability of mpDYCI to capture the intratumoral heterogeneity. Low voxelwise correlations between each pair of mpDYCI metrics (correlation coefficient ≤ 0.33 except for one pair) suggested that each metric provides complementary information. Furthermore, mpDYCI exhibited the potential to help differentiate treatment-related effects from true tumor progression in brain metastases. Conclusion With a single 7.5-minute scan and single-dose contrast media injection, mpDYCI can simultaneously quantify perfusion, permeability, water efflux, and susceptibility, thereby enabling comprehensive voxelwise characterization of brain tumors. Keywords: MR Perfusion, CNS, Brain/Brain Stem, Tumor Immune Microenvironment, Reconstruction Algorithms, MR-Dynamic Contrast Enhanced, MR Imaging, Brain Tumor Heterogeneity, Multiparametric MR Imaging, Dynamic Contrast-enhanced MRI, Dynamic Susceptibility Contrast MRI, Quantitative Susceptibility Mapping Supplemental material is available for this article. © RSNA, 2025.
引用
- Chen Y, Xiao J, Cen S, et al. Multiparametric Dynamic Contrast Imaging for Voxelwise Quantitative Assessment of Brain Tumors. Radiol Imaging Cancer. 2025. PMID: 41002286. doi:10.1148/rycan.250049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。